@文章{info:doi/10.2196/35514，作者=“Cucciare, Michael A和Abraham, Traci H和Kemp, Lakiesha和White, Penny和Marchant, Kathy和Hagedorn, Hildi J和Humphreys, Keith”，标题=“通过患者拥有最终结果协议来适应消除药物，促进美国退伍军人苯二氮平类药物的停止:与美国退伍军人和国家退伍军人健康管理局领导的焦点小组研究"，期刊="J Med Internet Res"，年="2022"，月="9"，日="19"，卷="24"，数="9"，页="e35514"，关键词="self-taper;电子自助;长期使用苯二氮卓类药物;美国退伍军人;背景:长期依赖处方苯二氮卓类药物是一个公共健康问题。通过患者最终结果的所有权(EMPOWER)消除药物是一种很有前途的自我管理干预措施，它以印刷小册子的形式直接提供给患者，对促进老年人减少和停用苯二氮卓类药物有效。EMPOWER有很大的潜力使大型卫生保健系统受益，如美国退伍军人健康管理局(VHA)，该管理局照顾许多长期使用苯二氮卓类药物的退伍军人。目的:我们的目的是调整原EMPOWER小册子材料的电子交付，并在接受VHA护理的美国退伍军人中使用，这些退伍军人长期使用苯二氮卓。方法:我们使用了分析、设计、开发、实施和评估的元素，一个在教学设计领域常用的框架，来指导迭代适应EMPOWER电子交付(EMPOWER- ed)的定性方法。 We conducted 3 waves of focus groups with the same 2 groups of VHA stakeholders. Stakeholders were VHA-enrolled veterans (n=16) with medical chart evidence of long-term benzodiazepine use and national VHA leaders (n=7) with expertise in setting VHA policy for prescription benzodiazepine use and developing electronically delivered educational tools for veterans. Qualitative data collected from each wave of focus groups were analyzed using template analysis. Results: Themes that emerged from the initial focus groups included veterans' anxiety about self-tapering from benzodiazepines and prior negative experiences attempting to self-taper without support. Participants also provided feedback on the protocol's look and feel, educational content, the tapering protocol, and website functionality; for example, feedback from policy leaders included listing, on the cover page, the most commonly prescribed benzodiazepines to ensure that veterans were aware of medications that qualify for self-taper using the EMPOWER-ED protocol. Both groups of stakeholders identified the importance of having access to supportive resources to help veterans manage sleep and anxiety in the absence of taking benzodiazepines. Both groups also emphasized the importance of ensuring that the self-taper could be personalized and that the taper instructions were clear. The policy leaders emphasized the importance of encouraging veterans to notify their provider of their decision to self-taper to help facilitate provider assistance, if needed, with the taper process and to help prevent medication stockpiling. Conclusions: EMPOWER-ED is the first direct-to-patient electronically delivered protocol designed to help US military veterans self-taper from long-term benzodiazepine use. We used the Analysis, Design, Development, Implementation, and Evaluation framework to guide the successful adaption of the original EMPOWER booklet for use with this population and for electronic delivery. The next step in this line of research is to evaluate EMPOWER-ED in a randomized controlled trial. ", issn="1438-8871", doi="10.2196/35514", url="//www.mybigtv.com/2022/9/e35514", url="https://doi.org/10.2196/35514", url="http://www.ncbi.nlm.nih.gov/pubmed/36121697" }